Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

27.47
-1.3000-4.52%
Volume:1.66M
Turnover:46.20M
Market Cap:1.95B
PE:-13.60
High:30.50
Open:28.86
Low:25.61
Close:28.77
52wk High:30.50
52wk Low:13.60
Shares:70.96M
Float Shares:66.05M
Volume Ratio:2.52
T/O Rate:2.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0200
EPS(LYR):-1.0800
ROE:-72.31%
ROA:-24.14%
PB:24.25
PE(LYR):-25.44

Loading ...

Jazz Wins FDA Approval for Ziihera Regimens in First-Line HER2+ Gastroesophageal Cancer, Triggering USD 250 Million Zymeworks Milestone

Reuters
·
Yesterday

U.S. FDA Approves Ziihera® (Zanidatamab-Hrii) with and Without Tislelizumab Plus Chemotherapy in First-Line Her2+ Advanced Gastroesophageal Adenocarcinoma

THOMSON REUTERS
·
Yesterday

Truist Financial Keeps Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
Aug 13

Zymeworks Management Attends Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Aug 11

Zymeworks Price Target Raised to $44.00/Share from $40.00 by B. Riley Securities

Dow Jones
·
Aug 11

Ireland's Theravance Biopharma Q2 Revenue Rises 11% but Misses Estimates

Reuters
·
Aug 10

B. Riley Adjusts Zymeworks Price Target to $44 From $40, Maintains Buy Rating

MT Newswires Live
·
Aug 10

Zymeworks price target raised to $32 from $31 at Truist

TIPRANKS
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Zymeworks Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Zymeworks Revenue Drops 90.57% to $4.6 Million in FY26 Q2; Net Loss Widens to $45 Million

Reuters
·
Aug 07

Zymeworks Q2 EPS $(0.62) Misses $(0.41) Estimate, Sales $4.590M Miss $18.011M Estimate

Benzinga Earnings
·
Aug 07

Zymeworks Q2 EPS USD -0.62 VS. Ibes Estimate USD -0.46

THOMSON REUTERS
·
Aug 07

Zymeworks Q2 Operating Expenses USD 46.77 Million

THOMSON REUTERS
·
Aug 07

Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 07

Zymeworks is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 06

Analysts Are Bullish on These Healthcare Stocks: Charles River Labs (CRL), Zymeworks (ZYME)

TIPRANKS
·
Aug 06

Zymeworks price target raised to $51 from $46 at H.C. Wainwright

TIPRANKS
·
Aug 06

Zymeworks Inc. Expected to Post a Loss of 46 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Zymeworks (ZYME) Receives a Buy from B. Riley Securities

TIPRANKS
·
Jul 30